Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma. - Wikidata - wikimedia - TriplyDB

Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma.

Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma.

http://www.wikidata.org/entity/Q33394925

about

Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy Promising therapeutic targets in neuroblastoma Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG)Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.Radionuclide therapy of adrenal tumors.Clinical research on rare diseases of children: neuroblastoma.Norepinephrine Transporter as a Target for Imaging and Therapy.Radionuclides in oncology clinical practice - review of the literature.Iodine-131 metaiodobenzylguanidine therapy for neuroblastoma: reports so far and future perspective.Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy: 123I-MIBG Versus Posttherapy 131I-MIBG Imaging.

P2860

Q34543646-A2AA9B16-D628-45D7-A154-5139FAD04321 Q36055313-B8181EB2-2067-4625-9414-8A603CD0961A Q36167173-600E7ECA-6647-441F-B5A1-0D10879813C2 Q38014527-181359CB-25ED-4C99-AA7A-1814039B9630 Q38020428-7389443B-C801-4F1B-BD4E-A7A46A5B9301 Q38791761-3582083F-93D3-4F21-9F52-E5DA5D9E76BD Q47867820-DE3D42C6-6866-4BC0-B84D-6375CB982C4F Q47916271-6F8D293C-CD08-47CA-98E5-4621C2DA99CE Q51125396-3DBB2B8C-968E-4C7A-99A8-A40AE200DC52 Q53133932-642B203A-3FAC-4556-93B1-ED8A748A881C

P2860

Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma.

http://www.wikidata.org/entity/Q33394925

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Safety and efficacy of tandem ...... psed/refractory neuroblastoma.

@ast

Safety and efficacy of tandem ...... psed/refractory neuroblastoma.

@en

type

label

Safety and efficacy of tandem ...... psed/refractory neuroblastoma.

@ast

Safety and efficacy of tandem ...... psed/refractory neuroblastoma.

@en

prefLabel

Safety and efficacy of tandem ...... psed/refractory neuroblastoma.

@ast

Safety and efficacy of tandem ...... psed/refractory neuroblastoma.

@en

P1433

Q33394925-9F130720-7BDA-4ADA-A7D4-4C91593F8CA6

P1476

Q33394925-3F37A5FA-1B33-45C1-B6E0-EE543C48E52F

P2093

Q33394925-4A45715F-2134-473C-818F-D5E1762C713B

Q33394925-80987A23-06BF-4801-9996-CA27F4CC61BA

Q33394925-A4FF8D4B-C45D-4F21-991C-D23B10905FBC

Q33394925-B74FFAA2-D1BE-4611-B575-2D1A98AC3E1F

Q33394925-C48EFB41-320F-4895-AF0F-0F54E4D8634C

Q33394925-D446595C-7540-4B4E-973A-F1F3778ACFBE

Q33394925-F2292F17-99F7-460D-82DF-8482A5E124A7

P2860

Q33394925-1448C08E-5DC4-466F-BB66-74CD59126C28

Q33394925-211F11AA-0692-4905-9701-BF25D7DC847E

Q33394925-4158CC8D-7794-42CC-9E3E-6A6380DB40CE

Q33394925-43812EF1-D99F-4320-8FC9-E39D8218C4EE

Q33394925-9605C7A0-6519-456C-8BDC-EDE1B7E9973F

Q33394925-D3981DEC-FF61-4880-AA2E-D1E8FFD9A8C3

Q33394925-D9F24319-AFFC-4340-871D-01F2A6A1D9FF

P304

Q33394925-CB16EB1C-559F-405C-B7E2-0827691D0B36

P31

Q33394925-68BA5C55-BFFB-4F9C-895F-CBAB4988AF1A

P356

Q33394925-0584DFA4-3D0E-48DF-98FB-6CEDCC7ED274

P433

Q33394925-1B31C1E2-7909-4094-8D40-FAB4F55B9379

P478

Q33394925-AECC1659-D908-4945-9E63-3287B8A4505E

P577

Q33394925-16B2522B-BB81-4C44-A367-A640EBF66ED5

P698

Q33394925-3D7BDC43-C914-4FEB-95AA-FFE586CB49A3

P356

P1433

Pediatric Blood & Cancer

P1476

Safety and efficacy of tandem ...... psed/refractory neuroblastoma.

@en

P2093

Barbara McGlynn

http://www.w3.org/2001/XMLSchema#string

Diane Baniewicz

http://www.w3.org/2001/XMLSchema#string

Hongming Zhuang

http://www.w3.org/2001/XMLSchema#string

Jennifer Saggio

http://www.w3.org/2001/XMLSchema#string

John M Maris

http://www.w3.org/2001/XMLSchema#string

Kelsey Johnson

http://www.w3.org/2001/XMLSchema#string

Yael P Mosse

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients

Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.

Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.

Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.

Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.

P304

1124-1129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.23062

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21495159

http://www.w3.org/2001/XMLSchema#string